CME Group, Weatherford International, RPM International And Other Big Stocks Moving Higher On Wednesday

Arrowhead Pharmaceuticals To Present Data On Plozasiran In Patients With Severe Hypertriglyceridemia At European Society Of Cardiology Congress

Arrowhead Pharma’s REDEMPLO Authorized In EU; Now Prescribable And Reimbursable In Germany For Familial Chylomicronaemia Syndrome

REDEMPLO® (plozasiran) is listed in the Lauer-Taxe® database as an adjunct to diet to reduce triglyceride levels in adult patients with familial chylomicronaemia syndrome (FCS), diagnosed either based on clinical

HC Wainwright & Co. Maintains Buy on Arrowhead Pharma, Raises Price Target to $120

HC Wainwright & Co. analyst Patrick R. Trucchio maintains Arrowhead Pharma (NASDAQ:ARWR) with a Buy and raises the price target from $115 to $120.

Arrowhead Pharma Q3 EPS $(1.36) Misses $(1.32) Estimate, Sales $75.253M Beat $54.294M Estimate

Arrowhead Pharma (NASDAQ:ARWR) reported quarterly losses of $(1.36) per share which missed the analyst consensus estimate of $(1.32) by 3.03 percent. This is a 7.94 percent decrease over losses of $(1.26) per share from

Shares of crypto-linked stocks are trading higher as Bitcoin's price rises above $80,000 as the digital token extends its rally.

Shares of crypto-linked companies are trading higher amid continued Bitcoin price momentum after multiple catalysts, including CFTC Chair Selig recently saying the commission will use its authority to establish a regulatory framework for crypto markets even without Clarity Act passage Also, prediction markets show expectations for Clarity Act becoming law by spring 2027 have risen to 42%, almost doubling from earlier this month.